Complete the form below, then stop by the Medtronic booth on Saturday, December 11 | 1-2 PM CT and receive a demo InPenTM smart insulin pen to use for your educational needs.
Humalog® is a registered trademarks of Eli Lilly and Company. Fiasp® and Novolog® are registered trademarks of Novo Nordisk A/S. Lantus® is a registered trademark of Sanofi-Aventis U.S. LLC.
IMPORTANT SAFETY INFORMATION FOR INPEN™ SMART INSULIN PEN:
The InPenTM is a home-use reusable pen injector for single-patient use by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for the self-injection of a desired dose of insulin and for calculating an insulin dose or carbohydrate intake based on user entered data. A healthcare professional must assist in dosage programming of the device prior to use, based on various patient-specific criteria and targets. The InPenTM requires a prescription. For additional product and safety information, please consult the Instructions for Use and bit.ly/InPenSafety.